Furthermore, the combined data from our studies strongly suggest that the antitumor efficacy of SPEDOX-6 may be inversely correlated with FcRn expression level in cancer cells, as expected based on the FcRn-mediated HSA recycling mechanism. The gene discussed is FCGRT; the disease is cancer.